 Connection
Larry Allen to Clinical Trials as Topic
This is a "connection" page, showing publications Larry Allen has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.515 |
|
|
|
-
Allen LA. End-point selection for acute heart failure trials. Heart Fail Clin. 2011 Oct; 7(4):481-95.
Score: 0.280
-
Ahmad T, Miller PE, McCullough M, Desai NR, Riello R, Psotka M, B?hm M, Allen LA, Teerlink JR, Rosano GMC, Lindenfeld J. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. Eur J Heart Fail. 2019 Sep; 21(9):1064-1078.
Score: 0.121
-
Allen LA, Jolicoeur EM, Melloni C, Lopes RD, Chan MY, Majidi M, Piccini JP, Berger JS, Katz JN, Shah BR. Highlights from American Heart Association, November 4-7, 2007, Orlando, Florida, USA. Late-breaking trials summary. Am Heart J. 2008 Apr; 155(4):615-23.
Score: 0.054
-
Piccini JP, Allen LA, Kudenchuk PJ, Page RL, Patel MR, Turakhia MP. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association. Circulation. 2016 Apr 26; 133(17):1715-27.
Score: 0.024
-
Thompson LE, Bekelman DB, Allen LA, Peterson PN. Patient-reported outcomes in heart failure: existing measures and future uses. Curr Heart Fail Rep. 2015 Jun; 12(3):236-46.
Score: 0.023
-
Adams GL, Mills JS, Melloni C, Allen LA, Jolicoeur EM, Wang T, Chan M, Majidi M, Lopes RD. Highlights from the 56th annual scientific sessions of the American College of Cardiology: March 25 to 27, 2007, Atlanta, Georgia. Am Heart J. 2007 Aug; 154(2):247-59.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|